This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Helmholtz-Zentrum Für, Infektionsforschung Gmbh. Active years: 2021.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2021
Title: Antje Ritter: Innovator in Cystobactamide Derivatives
Introduction
Antje Ritter is a prominent inventor based in Braunschweig, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating bacterial infections. Her work is characterized by a commitment to innovation and scientific advancement.
Latest Patents
Antje Ritter holds a patent for cystobactamide derivatives. The present invention relates to novel derivatives of cystobactamides of formula (Ib) and their use for the treatment or prophylaxis of bacterial infections. This patent highlights her dedication to addressing critical health challenges through innovative solutions.
Career Highlights
Throughout her career, Antje has worked with esteemed organizations, including Helmholtz-Zentrum für Infektionsforschung GmbH. Her role in these institutions has allowed her to contribute to groundbreaking research and development in the field of infectious diseases.
Collaborations
Antje Ritter has collaborated with notable colleagues, including Giambattista Testolin and Mark Brönstrup. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries.
Conclusion
Antje Ritter's work in developing cystobactamide derivatives exemplifies her commitment to advancing medical science. Her contributions are vital in the ongoing fight against bacterial infections, showcasing the importance of innovation in healthcare.